Masimo Corporation: Here Are the 6 Most Critical Factors Shaping Its Performance in 2025 & Beyond!

Masimo Corporation, a global technology company focused on experienced healthcare solutions,
recently reported its financial results for the third quarter of 2024. The company’s healthcare
segment demonstrated robust performance, with revenues reaching $343 million, showcasing a
12% year-over-year growth. This growth was attributed to increased consumable and service
revenues, although partially offset by a decline in capital equipment sales. The gross margin for
healthcare improved to 62.9%, a notable year-over-year increase driven primarily by manufacturing efficiencies from relocating operations to Malaysia. However, the non-healthcare segment faced challenges, recording a revenue of $161 million, marking a 6% decrease, influenced by sluggish consumer demand in luxury and housing markets.